Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Novel therapeutic agents for Alzheimer's disease reported in recent AstraZeneca patent

Sep. 3, 2007

GW completes patient recruitment for pivotal phase III trial of Sativex

Aug. 31, 2007

Baxter and ADCS group agree to initiate phase III study of Gammagard Liquid

Aug. 31, 2007

Memory Pharmaceuticals begins phase I clinical trial of R-4996/MEM-63908

Aug. 31, 2007

PKMzeta activity appears necessary for long-term memory maintenance

Aug. 31, 2007

Results of phase III studies of galantamine in Alzheimer's disease reported

Aug. 31, 2007

Enrollment complete for phase III trial of Zingo in adults

Aug. 30, 2007

Once-daily Seroquel XR approved in the Netherlands for schizophrenia

Aug. 30, 2007

E.U. approves new formulation of Rebif for relapsing MS

Aug. 30, 2007

IDEAL extension reveals long-term safety of rivastigmine patch in Alzheimer's disease

Aug. 30, 2007

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...